Please join our excellent speakers who will discuss a range of topics related to the drug development and clinical trial process. From the underlying translational science to phase I trial design and beyond, to the incorporation of genomics and precision medicine in trials and in practice.
DATE: 1st Thursday of the month (unless otherwise specified)
TIME: 16:30 – 17:30 (Melbourne Time)
LOCATION: Online Webinar
The series will run across 2022/23
For enquiries, please contact Sathya Manoharan, Early Drug Development Fellow (PeterMac 2022/23) on [email protected]
| Date | Topic | Summary |
|---|---|---|
| 21st July 2022 | Phase I Trial Design (now available on-demand, password access only) Jayesh Desai and Sophia Frentzas | Broad Overview of the Program Introduction to Drug Development Drug development trial design in 2022 Pharmacology/PD basics and applied sciences |
| 4th Aug 2022 | Trials 101 (now available on-demand, password access only) Ben Tran and Mark Voskoboynik | Patient selection, start dates and DLT period Pre-consent and consent, eligibility Nuances of escalation versus expansion RECIST and irRECIST, AEs, SAEs and practical GCP issues |
| 1st Sept 2022 | Kinase inhibition/targeting kinases: what makes a good oncogenic target? (now available on-demand, password access only) Grant McArthur and Stephen Luen | Genomics in drug development / clinical practice Kinase inhibitors vs cytotoxics vs IO from a drug development perspective |
| 6th Oct 2022 | Cancer Immunology: Part 1 (now available on-demand, password access only) Paul Neeson and Stephen Luen | Underlying science Potential targets/agents |
| 3rd Nov 2022 | Cancer Immunology: Part 2 (now available on-demand, password access only) Paul Neeson and Stephen Luen | Complex biomarkers |
| 1st Dec 2022 | Genomics and Next Generation Sequencing (now available on-demand, password access only) Kortnye Smith | Basic principles of precision medicine Genomic testing options Interpreting results: issues and challenges Case studies |